Abstract
Infection is a major cause of treatment-related morbidity and mortality in pediatric acute lymphoblastic leukemia (ALL). Most children with ALL who develop life-threatening bacterial infections do so during induction therapy. We describe a rare case of ALL presenting simultaneously with Streptococcus agalactiae group B Streptococcus bacteremia and meningitis in a 3-year-old girl. She received appropriate antimicrobial therapy and a 2-drug early induction regimen consisting of vincristine and dexamethasone, leading to slow neurologic recovery and a favorable initial response to anti-neoplastic therapy as evidenced by minimal residual disease of 1.12% on day 15 of induction.
Copyright © 2024 Wolters Kluwer Health, Inc. All rights reserved.
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols* / therapeutic use
-
Bacteremia / drug therapy
-
Bacteremia / microbiology
-
Child, Preschool
-
Dexamethasone* / administration & dosage
-
Dexamethasone* / therapeutic use
-
Female
-
Humans
-
Meningitis, Bacterial / diagnosis
-
Meningitis, Bacterial / drug therapy
-
Meningitis, Bacterial / microbiology
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / complications
-
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma* / drug therapy
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / complications
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / drug therapy
-
Streptococcal Infections* / drug therapy
-
Streptococcal Infections* / microbiology
-
Streptococcus agalactiae*
-
Vincristine / administration & dosage
-
Vincristine / therapeutic use
Substances
-
Dexamethasone
-
Vincristine